Trial intelligence / Profile preview

BMS-830216 in Obese Subjects

NCT00909766Phase 2Completed

Sponsor
Bristol Myers Squibb
Start
Aug 2009
Primary completion
Jun 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of BMS-830216 in obesity, sponsored by Bristol Myers Squibb. Started Aug 2009; status: completed.

02

Drugs

BMS-830216
03

Conditions

obesity

Beyond the preview

Go deeper on NCT00909766.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00909766.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call